Direct Biologics Gets Us Fda Nod To Proceed With Phase 3 Trial Of Ev Drug Exoflo To Treat Ards Due To Covid 19

Direct Biologics Gets Us Fda Nod To Proceed With Phase 3 Trial Of Ev Drug Exoflo To Treat Ards Due To Covid 19

By, Admin 25 April 2022

Direct Biologics, A Regenerative Biotechnology Company With A Groundbreaking Extracellular Vesicle (Ev) Platform Technology, Announced That The Us Fda Has Approved The Company To Proceed With Its Phase 3 Clinical Trial Using Its Investigational Ev Drug, Exoflo, To Treat Acute Respiratory Distress Syndrome (Ards) Due To Covid-19.According To A Company Press Release, Direct Biologics Is The First And Only Ev Company To Receive Fda Phase 3 Approval For An Investigational New Drug (Ind) Indication To Date. The Phase 3 Trial Will Be Conducted Under The Auspices Of The First Regenerative Medicine Advanced Therapy (Rmat) Designation Approved By The Fda For An Ev Therapeutic, Making Direct Biologics One Of Only 70 Companies In The History Of The Fda To Have Been Officially Awarded Rmat. Like The Fast Track And Breakthrough Designations, The Rmat Was Created By The Fda To Expedite Approval For Promising Regenerative Medicines Which Demonstrate The Ability To Treat Serious Life-Threatening Diseases.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!